T. Rowe Price Associates
MDLN

T. Rowe Price Associates’s Medline Inc MDLN Stock Holding History

T. Rowe Price Associates’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194M Sell
4,923,437
-687,405
-12% -$27.7M 0.02% 518
2026
Q1 		$250M Sell
5,610,842
-1,714,262
-23% -$75.7M 0.03% 406
2025
Q4 		$308M Buy
+7,325,104
New +$309M 0.03% 351

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates's MDLN Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Medline Inc (MDLN) stake by 12% in Q2 2026, selling an estimated $27.7M and leaving 4,923,437 shares worth $194M. The position accounts for 0.02% of the portfolio, ranked #518.

T. Rowe Price Associates first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $308M in Q4 2025. 408 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • T. Rowe Price Associates held 4,923,437 shares of Medline Inc worth $194M as of Q2 2026.
  • T. Rowe Price Associates sold 687,405 Medline Inc shares in Q2 2026, an estimated $27.7M.
  • Medline Inc made up 0.02% of T. Rowe Price Associates's portfolio in Q2 2026, its #518 holding.
  • T. Rowe Price Associates first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • T. Rowe Price Associates's Medline Inc position peaked at $308M in Q4 2025.
  • 408 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.